IDEC and Caprion Pharmaceuticals to Search for Novel Cancer Antigen Targets
By Business Review Editor
Pharma Deals Review: Vol 2002 Issue 28 (Table of Contents)
Published: 2 Sep-2002
DOI: 10.3833/pdr.v2002.i28.1003 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
IDEC Pharmaceuticals enlisted Caprion to collaborate on the discovery of novel antigen targets in the development of anticancer therapeutics using Caprion’s proprietary subcellular proteomics discovery platform CellCarta™...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS